Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 10.2.2023MEDOCHEMIE Ltd. (MOE)9445BZEPILEN 1 g (plo ijf 10x1 g (liek.inj.skl.))30.1.2023O
 10.2.2023MEDOCHEMIE Ltd. (MOE)9445BZEPILEN 1 g (plo ijf 10x1 g (liek.inj.skl.))8.2.2023R
 10.2.2023CZ Pharma s.r.o. (CZP)9837DAmoxicillin/Clavulanic Acid Olikla 1 000 mg/200 mg prášok na injekčný/infúzny roztok (plo ijf 50x20 ml (liek.inj.skl.))14.2.2023U
 10.2.2023Mylan Pharmaceuticals Limited (MLB-IE-1)4035BTadalafil Mylan 20 mg filmom obalené tablety (tbl flm 4x20 mg (PVC/PE/PVDC/Al))28.2.2023Z
 10.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)15868Zinnat 125 mg (tbl flm 10x125 mg (blis.OPA/Al/PVC))26.1.2023R
 10.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)15869Zinnat 250 mg (tbl flm 10x250 mg (blis.OPA/Al/PVC))26.1.2023R
 10.2.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)15870Zinnat 500 mg (tbl flm 10x500 mg (blis.OPA/Al/PVC))9.2.2023R
 9.2.2023Mundipharma Gesellschaft m.b.H. (MUP-A-2)92282Sevredol 10 mg (tbl flm 60x10 mg (blis.PVDC/PVC))13.2.2023O
 9.2.2023CSL Behring GmbH (CSL)50936Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml (liek.inj.skl.))9.2.2023O
 9.2.2023CSL Behring GmbH (CSL)50935Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml (liek.inj.skl.))9.2.2023O
 9.2.2023CSL Behring GmbH (CSL)50934Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x50 ml (liek.inj.skl.))9.2.2023O
 9.2.2023Laboratorios Salvat, S.A. (LBI)2323AInfalin duo 3 mg/ml + 0,25 mg/ml ušná roztoková instilácia (int ots 1x10 ml (fľ.PE s kvapkadlom))9.2.2023R
 9.2.2023Adamed Pharma S.A. (AFD)2961BRAMIZEK 5 mg/5 mg tvrdé kapsuly (cps dur 98x5 mg/5 mg (blis.PA/Al/PVC/Al))9.2.2023O
 9.2.2023Adamed Pharma S.A. (AFD)2973BRAMIZEK 10 mg/5 mg tvrdé kapsuly (cps dur 28x10 mg/5 mg (blis.PA/Al/PVC/Al))28.4.2023Z
 9.2.2023Adamed Pharma S.A. (AFD)2981BRAMIZEK 10 mg/5 mg tvrdé kapsuly (cps dur 98x10 mg/5 mg (blis.PA/Al/PVC/Al))17.3.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)